About Amplifyer Bio
Amplifyer Bio is a Healthcare company based in Lexington (United States) founded in 2023. Developer of liquid biopsy solutions for early cancer detection and monitoring. Amplifyer Bio has raised $7.08 million across 1 funding round. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its competitors include Guardant Health, GRAIL and Natera; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2023 and based in Lexington, United States, Amplifyer Bio operates in the biotechnology sector focused on oncology diagnostics. A platform is provided that incorporates priming agents alongside existing liquid biopsy methods to analyze cell-free DNA in blood samples. This approach supports early detection and ongoing monitoring of cancer, with operations centered on advancing non-invasive diagnostic tools for clinical use.
- Headquarters Lexington, United States
- SectorsHealthcare
- Email••••••••
- Website amplifyer.bio
- Social LinkedIn
- Total Equity Funding$7.08M (USD)
in 1 rounds
- Latest Funding Round$7.08M (USD), Series A
Sep 2024
Funding Insights of Amplifyer Bio
Amplifyer Bio has successfully raised a total of $7.08M through 1 strategic funding round. The most recent funding activity was a Series A round of $7.08 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.08M
- Total Rounds 1
- Last Round Series A — $7.08M
- First Round $7.08M
(Sep 2024)
All 1 funding rounds of Amplifyer Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2024 | $7.08M | Series A | – | – | – |
Timeline of Amplifyer Bio
2 dated milestones of Amplifyer Bio across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Amplifyer Bio is founded.
- Funding First funding round of $7.1M.
Competitors of Amplifyer Bio
Amplifyer Bio has 3 listed competitors in our database, 3 of them funded. They include Guardant Health, GRAIL and Natera.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| guardanthealth.com | 2012 | Redwood, United States | $557.5M | 1,351 | Digital sequencing technology for cancer detection is developed. | |
| grail.com | 2016 | Menlo Park, United States | $2B | 491 | Circulating tumor DNA is screened for early cancer detection. | |
| natera.com | 2004 | Redwood, United States | $152.1M | 3,293 | Developer of cell-free DNA testing for oncology, women’s health, and organ health |
Detailed competitors of Amplifyer Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Amplifyer Bio (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Amplifyer Bio
Complete news archive for Amplifyer Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amplifyer Bio
Amplifyer Bio was founded in 2023 and raised its 1st funding round 1 year after it was founded.
Amplifyer Bio is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Amplifyer Bio is a funded company, having raised a total of $7.08M across 1 funding round to date. The company's 1st funding round was a Series A of $7.08M, raised on Sep 2024.
Founded in 2023 and based in Lexington, United States, Amplifyer Bio operates in the biotechnology sector focused on oncology diagnostics. A platform is provided that incorporates priming agents alongside existing liquid biopsy methods to analyze cell-free DNA in blood samples. This approach supports early detection and ongoing monitoring of cancer, with operations centered on advancing non-invasive diagnostic tools for clinical use.
Amplifyer Bio's top competitors include Guardant Health, GRAIL and Natera.